Tus kws kho mob
QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 09, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1571 - 1580 ntawm 4303
Tus kws kho mob
QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 09, 2021
Tus kws kho mob
BC-COM_PharmProgPolicyNotifctn_Eff-7.25.21.pdf
Tus kws kho mob
upcoming-policies-effective-august-2-2021.pdf
Tus kws kho mob
P36-21 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P34-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 2, 2021
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P3R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Tus kws kho mob
2021 June Bulletins
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021